Table 4

Multiple regression models on prediction of steroid-refractory GVHD

Model 1
Model 2
Model 3
OR (95% CI)POR (95% CI)POR (95% CI)P
Gut GVHD stage 1     
Gut GVHD stage 2 3.06 (0.77-12.1) .11   1.28 (0.22-7.52) .78 
Gut GVHD stage 3 13.7 (2.41-78.2) .003   6.88 (0.95-49.5) .056 
Calprotectin ≥ 100 μg/g   16.1 (1.76-147.6) .014 16.8 (1.70-165.3) .016 
α1-AT ≥ 1.5 mg/g dw   4.10 (0.98-17.1) .053 2.84 (0.60-13.4) .19 
Model LR 11.65  21.95  26.22*  
c index 0.747  0.833  0.863  
Corrected c index 0.733  0.827  0.826  
Model 1
Model 2
Model 3
OR (95% CI)POR (95% CI)POR (95% CI)P
Gut GVHD stage 1     
Gut GVHD stage 2 3.06 (0.77-12.1) .11   1.28 (0.22-7.52) .78 
Gut GVHD stage 3 13.7 (2.41-78.2) .003   6.88 (0.95-49.5) .056 
Calprotectin ≥ 100 μg/g   16.1 (1.76-147.6) .014 16.8 (1.70-165.3) .016 
α1-AT ≥ 1.5 mg/g dw   4.10 (0.98-17.1) .053 2.84 (0.60-13.4) .19 
Model LR 11.65  21.95  26.22*  
c index 0.747  0.833  0.863  
Corrected c index 0.733  0.827  0.826  

OR indicates odds ratio; CI, confidence interval; AT, antitrypsin; LR, likelihood ratio; and dw, dry weight.

*

P = .0007 vs model 1.

P = .12 vs model 2.

or Create an Account

Close Modal
Close Modal